Hereditary angioneurotic edema (HANE) results from the deficiency of the inhibitor of the first component of human complement (C1-INH). It is inherited as an autosomal dominant trait. Heterogeneity of this defect has been shown at the protein and mRNA level. Southern blot analysis of genomic DNA was performed after digestion with six different restriction endonucleases in 24 families affected with type 1 HANE (low antigenic and functional C1-INH levels) and five with type 2 (low functional C1-INH levels and normal or elevated levels of dysmorphic C1-INH). Blots were hybridized with a C1-INH cDNA probe of 1,227 bp. With one enzyme (Pst I), two different patterns of restriction fragment length polymorphism (RFLP) were detected. One was present in one kindred with type 1 HANE and the other appeared the same in one type 1 and in one type 2 family, thus indicating that each RFLP resulted from a different mutation. Analysis of a total of 34 members of these three families suggested that the polymorphisms are tightly linked to the mutation responsible for the disease. Using a 170-bp probe we showed that the three different mutations leading to these polymorphisms are located in the same region of the C1-INH gene. These data suggest that different mutations in the same region of the C1-INH gene are responsible for C1-INIT deficiency in these families. Most of these mutations are probably point mutations or other "minor" defects and do not appear to be due to major deletions or rearrangements.
Introduction
Hereditary angioneurotic edema (HANE)' is due to the deficiency of the inhibitor of the first component of human complement (C l-INH) and is inherited as an autosomal dominant trait (1) . The swelling ofthe subcutaneous tissue, or ofthe gastrointestinal or laryngeal mucosa (2) (3) (4) . Symptoms can be controlled by therapy with androgen derivatives (5) , and attacks can be reversed by the infusion of C1-INH plasma concentrate (6) . Heterogeneity of the defect has been shown at the protein and mRNA level (7) (8) (9) [10] ). This probe was isolated from a human liver cDNA library cloned into the plasmid pAT 153 (16 fig. 3 . Nonaffected members of these families show three major bands of 4.2, 2.9, and 2.7 kb. Individuals with HANE in families A and C have an additional band of 3.1 kb. In these subjects the 2.9-kb normal band appears half the intensity of the same band in nonaffected individuals. In family B the members with the disease have an additional band of 1.7 kb. The 2.9-kb normal band in these subjects is also half the intensity of the same band in nonaffected individuals.
Results
Genomic The "normal" pattern for Pst I consists of four fragments that hybridize with the probe, with sizes of 4.2, 2.9, 2.7, and < 0.5 kb (Fig. 1) . The smallest fragment is not shown in the figures.
Families A and C revealed, in addition to the normal pattern, a band of 3.1 kb (Fig. 1) . Bock et al. [10] ). This probe hybridized only with the 2.9-kb fragment in normal individuals, and with both the 2.9-kb and the variant (3.1 or 1.7 kb) fragments in the three families whose DNA is polymorphic (Fig. 2) . The family trees ofthese three families are shown in Fig. 3 . As expected, in each family, inheritance of the disease was consistent with that of an autosomal dominant trait. As shown, every individual tested who had HANE also demonstrated the polymorphism, whereas every individual tested who did not have the disease showed only the normal pattern. In families B and C, there were a total of 13 informative meioses with phase known. This corresponds to a lod of 3.913 at a maximum theta (recombinant fraction) indistinguishable from zero.
Discussion
The data presented here show that RFLPs in the C1-INH gene are unusual among patients with HANE. Southern blot analysis of DNA after digestion with different restriction endonucleases revealed polymorphism in only 3 of 29 families with HANE. This finding, together with previous data (8, 10), indi- (17) . Also, the observation that the polymorphisms were detected with only one restriction endonuclease indicates that even among these three families the molecular genetic defects are relatively minor. The most common abnormalities, therefore, probably are point mutations, or relatively small deletions or rearrangements. These results are in contrast with those of Stoppa-Lyonnet et al. (12), who detected polymorphic variants with several restriction endonucleases, suggesting major structural changes in the gene. The cDNA probe used in the studies described here was slightly larger and extended somewhat beyond each end of the cDNA used in their study (12, 18) . It is therefore unlikely that their probe would detect variants that would be missed with the probe used here. Their findings, together with the findings presented here, further emphasize the heterogeneity of the molecular genetic defects observed in HANE (7-9, 12). It seems likely that the polymorphisms detected in this study result from the mutations that are responsible for Cl -INH deficiency. It is clear from the lod score and the fact that no recombinants were observed that the polymorphisms are tightly linked to the mutation responsible for the disease. Definitive proof of this conclusion will require sequence analysis ofthe genes from these patients. The two type 1 families (families A and B), since they have different RFLPs must have different mutations. Family C has an RFLP that appears the same as that in family A. However, these must result from different mutations since the patients in family C synthesize a mutant protein (type 2 HANE), whereas the patients in family A do not (type 1 HANE). Each of the polymorphic fragments was detectable with a 1 70-bp probe that encodes amino acids 338-394; the normal 2.9-kb fragment was also detectable with this probe. Thus, each of the three variants resulted from alterations within the same region of the gene. The relationship of these variants to the intron-exon structure of the gene cannot yet be defined. The region of the gene affected differs from the region affected in three of the four previously described patients with RFLPs. These findings, however, at least suggest the possibility that particular regions of the gene may be more subject to mutation.
